Study to Assess Safety and Efficacy of Fexofenadine Hydrochloride (HCL) + Pseudoephedrine HCL Fixed Dose Combination in Indian Male and Female Participants With Allergic Rhinitis (AR) Who Are 12 Years and Above

NCT05720455 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

203

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis Allergic

Interventions

DRUG: Fexofenadine HCL and pseudoephedrine HCL

Sponsor

Sanofi